The reiteration of a Buy rating and maintenance of a $92 price target by Canaccord Genuity analyst Kyle Mikson indicates a positive outlook for Exact Sciences. This news is likely to have a positive impact on the stock price in the short term as it reaffirms the analyst's confidence in the company's potential.